2017-11-14T14:35:14-06:00 2016-12-31 BKD LLP 10001 REUNION PLACE SUITE 400 SAN ANTONIO TX 782164137 990 2016-01-01 208429619 QUALTEX LABORATORIES % BENJAMIN LOPEZ QUAL 2107579505 6211 IH 10 WEST SAN ANTONIO TX 78201 MARTIN J LANDON CEO 2107579505 2017-11-15 true Edward Del Conte CPA P01319569 2103419400 167.68.126.162 70238020173185000007 2017-11-14 P 7A6C93CF34E7DBB7E62309E11043C060008A5DA7 FA6B9AFEF5C7AFCEFF92881CCDE0E31744794694 2016 2017-02-10 21:41:12Z MARTIN J LANDON 6211 IH 10 WEST SAN ANTONIO TX 78201 112267901 false X WWW.QUALTEXLABS.ORG X 2007 AZ QUALTEX IS DEDICATED TO SUPPORTING GLOBAL PUBLIC SAFETY WITH THE TIMELY DELIVERY OF HIGH-QUALITY TESTING SERVICES FOR PATIENTS, DONORS, AND REGULATED BIOLOGICAL PRODUCTS. 1 0 285 3 0 0 0 0 119992188 109246321 337036 903162 1966795 1552715 122296019 111702198 0 0 0 0 16506388 16260939 0 0 0 106636631 97993176 123143019 114254115 -847000 -2551917 63183783 58001177 16260401 12968599 46923382 45032578 X QUALTEX LABORATORIES IS DEDICATED TO SUPPORTING GLOBAL PUBLIC SAFETY WITH THE TIMELY DELIVERY OF HIGH-QUALITY TESTING SERVICES FOR PATIENTS, DONORS, AND REGULATED BIOLOGICAL PRODUCTS. false false 106541304 110799036 QUALTEX LABORATORIES, A SUBSIDIARY OF BIOBRIDGE GLOBAL, IS FOCUSED ON SUPPORTING GLOBAL PUBLIC SAFETY AT ITS TEXAS AND GEORGIA LOCATIONS BY PROVIDING ADVANCED BIOLOGIC TESTING SERVICES FOR WHOLE BLOOD AND PLASMA AS WELL AS FOR OTHER HUMAN CELLS, TISSUE AND CELLULAR- AND TISSUE-BASED PRODUCTS (SEE SCHEDULE O FOR CONTINUATION). 106541304 true false false false false false false false false false true false false false true false true true false false false false false false false false false false false true false false false false false false false false false false false false false true true true false false true 31 0 true 285 true false false false false false false false false false false X 1 0 false false false false true false false true true true false true true true true true true false false false AZ GA X BENJAMIN LOPEZ 2107579505 6211 IH 10 WEST SAN ANTONIO TX 78201 X BIOBRIDGE GLOBAL SOLE MEMBER 1.0 3.0 X 0 0 0 EDWARD CARTER III COO (EFF. 02/2016) 50.0 0.0 X 279165 0 1726 DIRK JOHNSON COO (THRU 03/2016) 50.0 0.0 X 190920 0 8988 KELLI LYNNE RIGGINS VP LABORATORY SERVICES 50.0 0.0 X 151989 0 33615 JOSE RAUL GARCIA VP OF MARKETING & CUSTOMER REL 50.0 0.0 X 134874 0 31856 THOMAS SCOTT JONES VP SCIENTIFIC AFFAIRS 10.0 40.0 X 6689 173150 32151 LARRY CHARLES FRANZOI JR CORPORATE ACCOUNT EXECUTIVE 50.0 0.0 X 173909 0 29600 MICHAEL ALAN LINDENBAUM CORPORATE ACCOUNT EXECUTIVE 50.0 0.0 X 181557 0 21698 STEVEN ANDREW BEELER VP OPERATIONS 50.0 0.0 X 123369 0 10108 LINDA KAY MYERS CEO BBG (THRU 12/16) 0.0 50.0 X 0 434758 35943 1242472 607908 205685 14 true true false HAEMONETICS CORPORATION 24849 NETWORK PLACE CHICAGO IL 606731248 SOFTWARE MAINTENANCE 362395 ABBOTT LABORATORIES PO BOX 92679 CHICAGO IL 606752679 EQUIPMENT MAINT. 769015 BECKMAN COULTER INC DEPT CH 10164 PALATINE IL 600550164 EQUIPMENT MAINT. 382801 RUBIN POOR INC 155 MAPLEWOOD AVE 5 MAPLEWOOD NJ 07040 SOFTWARE DEV./MAINT. 241726 AEROTEK INC 3689 COLLECTION CTR DR CHICAGO IL 60693 TEMPORARY SERVICES 218868 5 X 0 CLIENT TESTING SERVICE FEES 621500 109246321 109246321 109246321 468865 468865 0 0 0 0 0 1000000 565703 434297 434297 434297 0 0 0 0 0 0 0 0 0 PURCHASE DISCOUNTS 621500 718362 718362 PURCHASE REBATES 621500 724737 724737 OTHER 621500 109616 109616 109616 109616 1552715 111702198 110799036 903162 0 0 0 0 655614 655614 0 12291877 12291877 561875 561875 1838714 1838714 912859 912859 0 15509 15509 19700 19700 0 0 0 560053 538898 21155 111524 111524 370118 370118 795295 795295 0 2570219 2570219 286677 286677 0 37032 37032 0 0 1417436 1417436 105010 1250 103760 TESTING EXPENSES & SUPPLIES 79433532 79433532 CUSTOMER FREIGHT 2968872 2968872 EQUIPMENT MAINTENANCE 1602520 1602520 SUPPORT&ADMINISTRATIVE FEES 7568196 7568196 131483 131483 114254115 106541304 7712811 0 1119285 634304 6866 0 0 0 25101503 20272851 0 0 0 0 0 0 4492423 2257587 638625 930593 36302912 20105436 16551396 16197476 13624785 14003309 0 0 0 0 1213340 1073340 435560 2631717 63183783 58001177 9497127 7036704 0 0 357167 0 0 0 0 0 0 0 5879638 5591175 0 0 526469 340720 16260401 12968599 X 46923382 45032578 0 0 0 0 46923382 45032578 63183783 58001177 X -2551917 475364 185749 X false true X true false X 708939 708939 10767413 2128667 8638746 24320604 17618685 6701919 505956 358084 147872 16197476 0 INTEREST RATE SWAP 340720 340720 112177562 475364 475364 111702198 111702198 114254115 114254115 114254115 SCHEDULE D, PART X, LINE 2 MANAGEMENT HAS EVALUATED THEIR INCOME TAX POSITIONS UNDER THE GUIDANCE INCLUDED IN ASC 740. BASED ON THEIR REVIEW, MANAGEMENT HAS NOT IDENTIFIED ANY MATERIAL UNCERTAIN TAX POSITIONS TO BE RECORDED OR DISCLOSED IN THE FINANCIAL STATEMENTS. X false true false false false false false false false false false EDWARD CARTER III COO (EFF. 02/2016) 238850 0 0 0 40315 0 0 0 1726 0 280891 0 DIRK JOHNSON COO (THRU 03/2016) 76800 0 113256 0 864 0 4702 0 4286 0 199908 0 JOSE RAUL GARCIA VP OF MARKETING & CUSTOMER REL 132421 0 0 0 2453 0 9587 0 22269 0 166730 0 THOMAS SCOTT JONES VP SCIENTIFIC AFFAIRS 6619 170560 0 0 70 2590 411 12630 3775 15335 10875 201115 LARRY CHARLES FRANZOI JR CORPORATE ACCOUNT EXECUTIVE 172165 0 0 0 1744 0 12636 0 16964 0 203509 0 MICHAEL ALAN LINDENBAUM CORPORATE ACCOUNT EXECUTIVE 178200 0 0 0 3357 0 12642 0 9056 0 203255 0 KELLI LYNNE RIGGINS VP LABORATORY SERVICES 149499 0 0 0 2490 0 11107 0 22508 0 185604 0 LINDA KAY MYERS CEO BBG (THRU 12/16) 0 421658 0 0 0 13100 0 20147 0 15796 0 470701 SCHEDULE J, PART I, LINE 1A HOUSING ALLOWANCE OR RESIDENCE FOR PERSONAL USE: DIRK JOHNSON -- $2,628.03 RENT SUBSIDY TREATED AS TAXABLE COMPENSATION SCHEDULE J, PART I, LINE 1B POLICY FOR PAYMENT OR REIMBURSEMENT OF CERTAIN EXPENSES: THE ORGANIZATION FOLLOWED THE TERMS OF THE COO'S EMPLOYMENT CONTRACT IN THE PAYMENT OF TEMPORARY HOUSING ALLOWANCE. SCHEDULE J, PART I, LINE 3 METHODS USED TO ESTABLISH TOP MANAGEMENT OFFICIAL COMPENSATION: THE ORGANIZATION RELIED ON BIOBRIDGE GLOBAL'S PROCESS THAT USED ONE OR MORE OF THE METHODS LISTED IN SCHEDULE J, PART 1, LINE 3 TO ESTABLISH THE TOP MANAGEMENT OFFICIAL'S COMPENSATION. FORM 990, PART III, LINE 4A PROGRAM SERVICE ACCOMPLISHMENT DESCRIPTION: IN 2016, QUALTEX LABORATORIES ACHIEVED SEVERAL SUCCESSES, TO INCLUDE: INCREASING WHOLE BLOOD TESTING BY 41%, BECAME ONE OF THE FIRST THREE LABORATORIES IN THE UNITED STATES TO BEGIN TESTING BLOOD DONATIONS FOR THE ZIKA VIRUS, ROLLOUT OF A LABORATORY MANAGEMENT SOFTWARE THAT WILL AUTOMATE TESTING PROCESS AND PROVIDE UP-TO-THE-MINUTE REPORTING CAPABILITIES. FORM 990, PART VI, LINE 6 CLASSES OF MEMBERS OR STOCKHOLDERS: QUALTEX LABORATORIES IS MANAGED BY ITS SOLE MEMBER, BIOBRIDGE GLOBAL. FORM 990, PART VI, LINE 8A DOCUMENTING MEETINGS OR WRITTEN ACTIONS UNDERTAKEN BY BOARD: MEETINGS HELD AND WRITTEN ACTIONS UNDERTAKEN WERE DOCUMENTED IN THE MINUTES OF THE MEETINGS OF BIOBRIDGE GLOBAL'S BOARD OF DIRECTORS. FORM 990, PART VI, LINE 9 MAILING ADDRESS: DIRK JOHNSON - 7417 COMIS DRIVE, N. RICHLAND HILLS, TX 76182 KELLI LYNNE RIGGINS - 13522 NORLAND DR, SAN ANTONIO, TX 78232 FORM 990, PART VI, LINE 11B PROCESS TO REVIEW THE FORM 990: THE ORGANIZATION ENGAGES AN OUTSIDE ACCOUNTING FIRM TO PREPARE THE FORM 990. ONCE PREPARED, THE RETURN IS REVIEWED BY THE FINANCIAL MANAGEMENT STAFF FROM BIOBRIDGE GLOBAL, A RELATED ORGANIZATION, PRIOR TO FILING THE RETURN. A COPY OF THE FORM 990 IS PROVIDED TO THE EXECUTIVE COMMITTEE OF THE BOARD OF DIRECTORS OF BIOBRIDGE GLOBAL PRIOR TO FILING. FORM 990, PART VI, LINE 12C MONITORING COMPLIANCE WITH CONFLICT OF INTEREST POLICY: A COPY OF THE ORGANIZATION'S CONFLICT OF INTEREST POLICY IS PROVIDED ANNUALLY TO ALL OFFICERS, KEY EMPLOYEES AND THE BOARD OF DIRECTORS OF BIOBRIDGE GLOBAL. IN ADDITION, QUESTIONNAIRES ARE GIVEN OUT ON AN ANNUAL BASIS TO ALL OFFICERS, KEY EMPLOYEES AND THE BOARD OF DIRECTORS OF BIOBRIDGE GLOBAL, WHICH COVER BUSINESS AND FAMILY RELATIONSHIPS AND VARIOUS ACTIVITIES THAT HAVE OCCURRED OVER THE COURSE OF THE YEAR. EVERY ATTEMPT IS MADE TO ENSURE THAT ALL FORMS ARE RETURNED. INDIVIDUALS WHO FAIL TO RETURN THE REQUESTED FORMS OR PROVIDE INCOMPLETE INFORMATION ARE CONTACTED BY THE ORGANIZATION. FORM 990, PART VI, LINE 15A REVIEW OF TOP MANAGEMENT OFFICIAL COMPENSATION: IN DETERMINING THE TOP MANAGEMENT OFFICIAL'S COMPENSATION, THE ORGANIZATION RELIED ON BIOBRIDGE GLOBAL'S PROCESS TO ASSIST IN COMPENSATION DECISIONS. THE PROCESS OF DETERMINING THE TOP MANAGEMENT COMPENSATION IN DISCLOSED IN THEIR FORM 990. FORM 990, PART VI, LINE 15B REVIEW OF OTHER OFFICERS' COMPENSATION: THE ORGANIZATION RELIED ON BIOBRIDGE GLOBAL'S PROCESS TO ASSIST IN COMPENSATION DECISIONS. THE PROCESS OF DETERMINING OTHER OFFICERS' COMPENSATION IS DISCLOSED IN THEIR FORM 990. FORM 990, PART VI, LINE 19 HOW DOCUMENTS ARE MADE AVAILABLE TO PUBLIC: ANY DOCUMENTS SUBJECT TO OPEN RECORD REQUIREMENTS ARE MADE AVAILABLE UPON REQUEST. FORM 990, PART XI, LINE 9 OTHER CHANGES IN NET ASSETS: CHANGE IN INTEREST RATE SWAP $185,749 SOUTH TEXAS BLOOD & TISSUE CENTER 6211 IH 10 WEST SAN ANTONIO TX 78201 237379332 BLOOD BANK TX 501(C)(3) 10 SEE PART VII true THE BLOOD & TISSUE CENTER FOUNDATION 6211 IH 10 WEST SAN ANTONIO TX 78201 431970952 SUPPORT ORG. TX 501(C)(3) 12A SEE PART VII true BIOBRIDGE GLOBAL 6211 IH 10 WEST SAN ANTONIO TX 78201 454765222 SUPPORT ORG. TX 501(C)(3) 12B NA false GENCURE 6211 IH 10 WEST SAN ANTONIO TX 78201 462216869 CEL & TIS SVS TX 501(C)(3) 10 SEE PART VII true HCSC - BLOOD CENTER 2171 28TH STREET SW ALLENTOWN PA 18103 231731796 BLOOD BANK PA 501(C)(3) 10 NA false false false false true false false false false false false true true false true true true true false false SOUTH TEXAS BLOOD & TISSUE CENTER K 791157 BOOK COST GENCURE L 602084 BOOK COST SOUTH TEXAS BLOOD & TISSUE CENTER L 7487227 BOOK COST SOUTH TEXAS BLOOD AND TISSUE CENTER D 18317793 LOAN BALANCE SCHEDULE R, PART II, COLUMN F DIRECT CONTROLLING ENTITY: THE ORGANIZATIONS SPECIFIED ARE ALL CONTROLLED BY BIOBRIDGE GLOBAL.